Affiliations 

  • 1 Institute of Biomedical Ethics and the History of Medicine, University of Zurich, Zurich, Switzerland
  • 2 School of Medicine, Deakin University, Melbourne, Victoria, Australia
  • 3 Division of Nephrology, Department of Medicine, Faculty of Medicine and Health Sciences, Stellenbosch University and Tygerberg Academic Hospital, Cape Town, South Africa
  • 4 Division of Nephrology and Immunity, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada
  • 5 Division of Nephrology and Hypertension, Department of Medicine, Saint Louis University, Saint Louis, Missouri, USA
  • 6 Division of Nephrology, Department of Medicine, University of Hong Kong, Hong Kong
  • 7 Division of Nephrology, Department of Medicine, Hospital Obrero 2-Caja Nacional de Salud, Universidad Mayor de San Simon School of Medicine, Cochabamba, Bolivia
  • 8 Hospital Privado-Universitario de Cordoba and Instituto Universitario de Ciencias Biomédicas, Cordoba, Argentina
  • 9 Department of Medicine, Chulalongkorn Hospital, Bangkok, Thailand
  • 10 Department of Pediatrics, University of Port Harcourt Teaching Hospital, Port Harcourt, Nigeria
  • 11 Department of Nephrology and Clinical Research Centre, Hospital Serdang, Jalan Puchong, Kajang, Selangor, Malaysia
  • 12 George Institute for Global Health India, New Delhi, India
  • 13 Department of Renal Medicine, Tan Tock Seng Hospital, Singapore
  • 14 School of Medicine, Addis Ababa University, Addis Ababa, Ethiopia
  • 15 Transplant Unit, Department of Surgery, Groote Schuur Hospital, University of Cape Town, Cape Town, South Africa
  • 16 Division of Nephrology and Hypertension, University of Cape Town, Cape Town, South Africa
  • 17 Intensive Care Nephrology and Transplantation Department, Hopital Tenon, Assistance Publique-Hôpitaux de Paris, Paris, France
  • 18 Department of Nephrology, Osmania Medical College and General Hospital, Hyderabad, Telangana, India
  • 19 School of Nursing, University of British Columbia, Vancouver, British Columbia, Canada
  • 20 Nephrology Section, Salisbury Veterans Affairs Health Care System, Salisbury, North Carolina, USA
Kidney Int Suppl (2011), 2020 Mar;10(1):e72-e77.
PMID: 32149011 DOI: 10.1016/j.kisu.2019.11.003

Abstract

Ethical issues relating to end-stage kidney disease (ESKD) care are increasingly being discussed by clinicians and ethicists but are still infrequently considered at a policy level or in the education and training of health care professionals. In most lower-income countries, access to kidney replacement therapies such as dialysis is not universal, leading to overt or implicit rationing of resources and potential exclusion from care of those who are unable to sustain out-of-pocket payments. These circumstances create significant inequities in access to ESKD care within and between countries and impose emotional and moral burdens on patients, families, and health care workers involved in decision-making and provision of care. End-of-life decision-making in the context of ESKD care in all countries may also create ethical dilemmas for policy makers, professionals, patients, and their families. This review outlines several ethical implications of the complex challenges that arise in the management of ESKD care around the world. We argue that more work is required to develop the ethics of ESKD care, so as to provide ethical guidance in decision-making and education and training for professionals that will support ethical practice in delivery of ESKD care. We briefly review steps that may be required to accomplish this goal, discussing potential barriers and strategies for success.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.